ABOUT LINK ALTERNATIF MBL77

Not all clients with CLL require therapy. In spite of all the latest innovations, the iwCLL nevertheless endorses watchful observation for people with asymptomatic sickness.86 This advice is predicated on at the least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).10